NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
3.500
-0.140 (-3.85%)
At close: Mar 6, 2026, 4:00 PM EST
3.698
+0.198 (5.67%)
After-hours: Mar 6, 2026, 7:45 PM EST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $403.52 million as of March 6, 2026. Its market cap has increased by 412.58% in one year.
Market Cap
403.52M
Enterprise Value
178.52M
1-Year Change
412.58%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $403.52M, an increase of 192.30%. That is a compound annual growth rate of 19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 403.52M | -12.06% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 441.12M |
| 4D Molecular Therapeutics | 440.71M |
| Altimmune | 438.94M |
| Assembly Biosciences | 437.50M |
| Solid Biosciences | 437.08M |
| Entrada Therapeutics | 418.32M |
| Upstream Bio | 414.48M |
| Atea Pharmaceuticals | 414.07M |